Stocktoria
Whitehawk Therapeutics, Inc. WHWK
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-06-26
Whitehawk Therapeutics, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $7.1M | $26.0M | $24.4M | $15.2M | $14.0M |
| R&D expense | $91.0M | $51.0M | $48.9M | $32.7M | $19.7M |
| SG&A expense | $29.8M | $36.7M | $44.5M | $40.2M | $18.5M |
| Operating income | -$114.4M | -$67.5M | -$71.9M | -$62.7M | -$111.2M |
| Interest expense | — | — | $231,000 | $230,000 | $665,000 |
| Income tax | $0 | $0 | $0 | $0 | $2,000 |
| Net income | -$20.6M | -$63.7M | -$65.8M | -$60.5M | -$110.1M |
| EPS (diluted) | $-0.33 | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
| Operating cash flow | -$97.4M | -$59.5M | -$59.7M | -$49.6M | -$22.4M |
| Free cash flow | -$98.0M | -$61.2M | -$63.6M | -$50.1M | -$22.5M |
| Cash & equivalents | $37.6M | $28.7M | $62.9M | $39.0M | $149.0M |
| Inventory | $0 | $5.3M | $6.4M | $1.9M | $0 |
| Total assets | $150.8M | $70.3M | $132.4M | $184.2M | $157.9M |
| Total liabilities | $14.5M | $17.8M | $27.2M | $25.9M | $21.5M |
| Shareholders' equity | $136.3M | $52.5M | $105.2M | $158.4M | $136.4M |
Source: SEC EDGAR filings · CIK 0001422142 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.